Definitive Contract 75F40121C00069

Award Date 7/11/21
Potential Completion Date 9/25/23
Potential Value $584K
Awardee
Vs4S LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20857, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Vs4S, LLC was awarded a $4 million firm fixed price definitive contract as an 8(a) set aside by the Department of Health and Human Services Food and Drug Administration (FDA) to provide training instructor services in support of the FDA Office of Training, Education and Development. The contract has a period of performance through May 2023 for delivery of training curriculum and instruction to FDA staff. Vs4S will draw on its experience as an incumbent contractor, having previously delivered...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $3,724,826.86 firm-fixed price definitive contract for new training and instructor services to Vs4S, LLC, an 8(a) certified small disadvantaged business. The contract will provide workforce development and organizational performance improvement solutions, including training services, curriculum development, and professional development programs in areas like regulatory compliance, hazardous materials...
The U.S. Food and Drug Administration (FDA) awarded a $2,932,576.44 sole source contract to Vs4S, LLC, an 8(a) certified small disadvantaged business, to provide training instructor services for courses on FDA-regulated products. The contract has an ultimate completion date of April 30, 2026. The contract was awarded as a follow-on to Vs4S's prior 8(a) set-aside contract with the FDA to provide instructional services at the agency's Silver Spring, Maryland facilities. Vs4S has extensive...
This is a $4,395,253.44 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, SBA-certified 8(a) small disadvantaged business joint venture. The contract is for business process integration and solution architecture services, with a performance period from April 29, 2024 to April 29, 2029. Vets Synergetic Group LLC holds two significant federal contract vehicles: a single-award Indefinite Delivery Contract (IDC)...
This is a firm fixed-price task order awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned small disadvantaged business structured as a limited liability company and small business joint venture. The contract is valued at $3,909,580.24 and has an ultimate completion date of December 4, 2025. The task order falls under a larger single-award Indefinite Delivery Contract (IDC) with the FDA valued at $99,883,020.00, which provides scientific support...
<p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>
This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services...
This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Bz-Jv LLC, an 8(a) joint venture small business. The contract, valued at $334,703.85, is for the CVM Adverse Drug Event Data Management Program, which includes records and information management services such as on-site document control, records management support, file room coordination, scanning, and document control center services. The contract was set aside for...
This contract is a new task order awarded to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture, under the FDA-Wide Scientific Support Indefinite Delivery Contract (IDC) 75F40124D00020. The task order is for one (1) pharmaceutical scientist to conduct product quality research for the Food and Drug Administration (FDA). The contract has a ceiling value of $197,644.80 and a period of performance through December 15, 2025. This task order is not set aside and is being awarded under...
This federal contract award with ID 75F40119D10039|75F40124F19022 was issued by the U.S. Food and Drug Administration (FDA) to the prime contractor, Computer Evidence Specialists, LLC (doing business as C E S), a minority-owned, service-disabled veteran-owned small business based in St. Augustine, Florida. The $623,741.94 firm fixed-price delivery order task order is to obtain 4,500 UBS, 1,050 A &amp; L's, 4,348 program management hours, non-inspection travel, and other direct costs to...

This is a firm fixed price award from the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) to Vs4S, LLC, a small disadvantaged business, for expertise in computer data integrity and data audit enforcement support services. The contract has a ceiling value of $584,377.01 and a completion date of September 25, 2023.

Vs4S, LLC is an 8(a) certified small disadvantaged business that has previously performed FDA, FEMA, and NIH contracts for training, curriculum development, and professional development programs. This award does not have a set-aside designation. The contract is being administered under the FDA and appears to be part of the agency's broader mission to ensure data integrity and enforcement within the drug evaluation and approval process.

Generated 8/28/24, 11:29 AM